Search

Your search keyword '"Corry, June"' showing total 632 results

Search Constraints

Start Over You searched for: Author "Corry, June" Remove constraint Author: "Corry, June"
632 results on '"Corry, June"'

Search Results

1. Update on olfactory neuroblastoma

2. International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma

9. Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statement

10. Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus Statement

13. Can Radiation Therapy Quality Assurance Improve Nasopharyngeal Cancer Outcomes in Low- and Middle-Income Countries: Reporting the First Phase of a Prospective International Atomic Energy Agency Study

14. De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?

15. Randomized Trial of Radiation Therapy With Weekly Cisplatin or Cetuximab in Low-Risk HPV-Associated Oropharyngeal Cancer (TROG 12.01) – A Trans-Tasman Radiation Oncology Group Study

16. International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma

18. Introducing: The Red Journal Gray Zone

19. Stereotactic Body Radiotherapy in Recurrent and Oligometastatic Head and Neck Tumours

22. Initial surgical management of sporadic medullary thyroid cancer: Guidelines based optimal care ‐ A systematic review

23. Radiotherapy quality assurance in the TROG 12.01 randomised trial and its impact on loco-regional failure

25. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma

27. Stereotactic Body Radiotherapy in Recurrent and Oligometastatic Head and Neck Tumours.

30. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma

36. Suppl Figure 4 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma

38. Suppl Figure 1 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma

39. Suppl Figure 2 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma

40. Suppl Figure 3 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma

41. Suppl Figure 5 from Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma

49. Current Radiotherapy Considerations for Nasopharyngeal Carcinoma

50. Evaluating new treatments for anaplastic thyroid cancer

Catalog

Books, media, physical & digital resources